Visits to three health systems — Mercy Health in Grand Rapids, Michigan; Henry Ford Health System in Detroit; and OSF HealthCare in Peoria, Illinois — showcase how they're thinking creatively about simulation, startups, 3D printing and more.
A new partnership between DMC and Ford Motor Company's non-emergency medical transportation service, Ford GoRide, enables patients with mobility challenges to get to and from appointments at specific medical facilities.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Through GM's ConnectedCare plan, nearly 24,000 General Motors salaried employees and their families in southeastern Michigan will be able to access Henry Ford providers. Employees can select the plan during the company's open enrollment this fall, and service will officially start at the beginning of 2019.
Primary care isn't so easy after all. Geared toward Medicare-eligible adults, Chicago-based Oak Street Health has a new way of rethinking healthcare and making primary care doctors heroes.
The car maker is exploring ways to use drivers' biometric data from wearables to create a safer driving experience. Its findings could also have an impact on ways to improve remote patient monitoring.
Clinical trials recruiting company Curelauncher is ramping up its sales and marketing team to work with more of the world’s biggest pharmaceutical companies. The Michigan-based startup says it already has two of the Big 5 as customers. By year’s end, it wants to double that number – and is looking at the likes of Novartis, […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Cancer drug developer ProNAi Therapeutics, which developed a nucleic acid-based DNA-interference technology to cause cancer cell death, has added nine new investors in an oversubscribed Series D round. The latest fundraise will help support Phase 2 clinical trials for its recurrent non-Hodgkin lymphoma treatment, follicular lymphoma, Richter’s transformation and large B-cell lymphoma, according to a […]
Retia Medical, an East Lansing, Michigan company that is developing a less-invasive hemodynamic monitor, has raised $7 million in a series A financing round.
Detroit Venture Partners wants its portfolio companies to move their operations to the heart of Detroit in the hopes of transforming the Motor City into a vibrant startup community like Boston and San Francisco, according to Xconomy Detroit.
Delphinus Medical Technologies Inc. has received $8 million in funding commitments to further develop an ultrasonic breast cancer detection device that could become an alternative to mammograms. The funding means that Delphinus can finally begin the process of commercializing its SoftVue device, which has undergone about 10 years of research and development. Unlike mammography, which […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The number of Midwest health care startups receiving investments could set a record this year. However, the startups reported winning far fewer dollars in the first nine months of the year than in either 2008 or 2007.
Among the items up for discussion: combining the research efforts at both institutions with an emphasis on translational research, and adding a new research center in TechTown, Wayne State's research and technology park. Wayne State received $115 million in grants last year and does strong research in areas of pediatric medicine and oncology, among others.
The Detroit Science Center will this fall include the clinical-trials process in its new health-care exhibit. It's created through a $100,000 National Institutes of Health grant and efforts at the University of Michigan Health System to increase the participation in trials. But can informed consent be fun?